Metabolic vulnerabilities in pleural mesothelioma

Area of Science:

• Oncology
• Cancer Metabolism
• Mesothelioma Research

Background:

• Mesothelioma is a rare cancer often diagnosed late, with a poor prognosis despite immunotherapy.
• Tumor metabolism is increasingly linked to mesothelioma's aggressiveness, resistance to therapy, and poor outcomes.
• Metabolic alterations in mesothelioma may stem from asbestos exposure, the pleural microenvironment, and genetic changes.

Purpose of the Study:

• To review current knowledge of mesothelioma metabolism.
• To highlight how genetic alterations influence metabolic phenotypes.
• To explore therapeutic strategies targeting metabolic vulnerabilities.

Main Methods:

• Literature review of mesothelioma metabolism.
• Analysis of genetic alterations (CDKN2A, MTAP, BAP1, NF2, TP53) and their impact on metabolism.
• Evaluation of experimental and therapeutic targeting of metabolic pathways.

Main Results:

• Key metabolic pathways (glycolysis, pentose phosphate pathway, nucleotide/amino acid/lipid metabolism) are interconnected and regulate cell survival.
• Metabolism influences the tumor microenvironment, redox balance, signaling, and nutrient exchange.
• Specific genetic alterations significantly impact mesothelioma's metabolic landscape.

Conclusions:

• A holistic view of interconnected metabolic pathways is essential for understanding mesothelioma.
• Targeting metabolic weaknesses presents opportunities for novel therapeutic strategies.
• Developing combination therapies based on metabolic insights may improve mesothelioma treatment.